Variant report
Variant | nsv1020221 |
---|---|
Chromosome Location | chr6:85942790-85964024 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:41)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:41 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr6:85960565-85960909 | Hela-S3 | cervix: | n/a | chr6:85960728-85960741 |
2 | CEBPB | chr6:85951266-85951468 | H1-hESC | embryonic stem cell: | n/a | chr6:85951443-85951455 chr6:85951420-85951431 chr6:85951419-85951432 |
3 | CEBPB | chr6:85952501-85952527 | HepG2 | liver: | n/a | n/a |
4 | CEBPB | chr6:85951250-85951574 | IMR90 | lung: | n/a | chr6:85951443-85951455 chr6:85951420-85951431 chr6:85951419-85951432 |
5 | CEBPB | chr6:85962382-85962498 | A549 | lung: | n/a | n/a |
6 | CEBPB | chr6:85951257-85951518 | HepG2 | liver: | n/a | chr6:85951443-85951455 chr6:85951420-85951431 chr6:85951419-85951432 |
7 | CEBPB | chr6:85951255-85951493 | A549 | lung: | n/a | chr6:85951443-85951455 chr6:85951420-85951431 chr6:85951419-85951432 |
8 | CEBPB | chr6:85951283-85951531 | K562 | blood: | n/a | chr6:85951443-85951455 chr6:85951420-85951431 chr6:85951419-85951432 |
9 | CTCF | chr6:85953564-85953593 | LNCaP | prostate: | n/a | n/a |
10 | CTCF | chr6:85960920-85961070 | HPAF | blood vessel: | n/a | n/a |
11 | CTCF | chr6:85945900-85945931 | GM13976 | blood: | n/a | n/a |
12 | CTCF | chr6:85958697-85958773 | Lung_OC | lung: | n/a | n/a |
13 | EBF1 | chr6:85954286-85954563 | GM12878 | blood: | n/a | n/a |
14 | FOS | chr6:85950436-85950846 | HUVEC | blood vessel: | n/a | n/a |
15 | FOS | chr6:85946478-85946611 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | FOS | chr6:85960758-85960895 | MCF10A-Er-Src | breast: | n/a | n/a |
17 | FOS | chr6:85960633-85960935 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | FOS | chr6:85960633-85960958 | MCF10A-Er-Src | breast: | n/a | n/a |
19 | FOS | chr6:85946417-85946531 | MCF10A-Er-Src | breast: | n/a | n/a |
20 | FOS | chr6:85960635-85960956 | MCF10A-Er-Src | breast: | n/a | n/a |
21 | KAP1 | chr6:85960469-85961375 | U2OS | brain: | n/a | n/a |
22 | KAP1 | chr6:85960018-85961186 | HEK293 | kidney: | n/a | n/a |
23 | KAP1 | chr6:85961686-85962231 | HEK293 | kidney: | n/a | n/a |
24 | MAFF | chr6:85952011-85952268 | HepG2 | liver: | n/a | chr6:85952079-85952097 |
25 | MAFK | chr6:85951918-85952196 | HepG2 | liver: | n/a | n/a |
26 | POLR2A | chr6:85952332-85952393 | HUVEC | blood vessel: | n/a | n/a |
27 | POLR2A | chr6:85943541-85943740 | MCF10A-Er-Src | breast: | n/a | n/a |
28 | POLR2A | chr6:85960726-85960926 | MCF10A-Er-Src | breast: | n/a | n/a |
29 | POLR2A | chr6:85961021-85961067 | MCF10A-Er-Src | breast: | n/a | n/a |
30 | POLR2A | chr6:85952937-85953033 | MCF10A-Er-Src | breast: | n/a | n/a |
31 | POLR2A | chr6:85951416-85951474 | MCF10A-Er-Src | breast: | n/a | n/a |
32 | SETDB1 | chr6:85961648-85962454 | U2OS | brain: | n/a | n/a |
33 | SETDB1 | chr6:85960491-85961221 | U2OS | brain: | n/a | n/a |
34 | SPI1 | chr6:85943352-85943653 | HL-60 | blood: | n/a | chr6:85943458-85943471 chr6:85943458-85943471 |
35 | STAT3 | chr6:85954988-85955124 | MCF10A-Er-Src | breast: | n/a | n/a |
36 | STAT3 | chr6:85960528-85961027 | MCF10A-Er-Src | breast: | n/a | chr6:85960791-85960814 chr6:85960791-85960800 chr6:85960788-85960802 chr6:85960789-85960800 chr6:85960790-85960799 |
37 | STAT3 | chr6:85960586-85960958 | Hela-S3 | cervix: | n/a | chr6:85960791-85960814 chr6:85960791-85960800 chr6:85960788-85960802 chr6:85960789-85960800 chr6:85960790-85960799 |
38 | STAT3 | chr6:85960394-85961011 | MCF10A-Er-Src | breast: | n/a | chr6:85960791-85960814 chr6:85960486-85960495 chr6:85960484-85960498 chr6:85960791-85960800 chr6:85960788-85960802 chr6:85960789-85960800 chr6:85960464-85960472 chr6:85960790-85960799 chr6:85960487-85960496 |
39 | STAT3 | chr6:85960602-85960986 | MCF10A-Er-Src | breast: | n/a | chr6:85960791-85960814 chr6:85960791-85960800 chr6:85960788-85960802 chr6:85960789-85960800 chr6:85960790-85960799 |
40 | STAT3 | chr6:85960630-85961111 | MCF10A-Er-Src | breast: | n/a | chr6:85960791-85960814 chr6:85960791-85960800 chr6:85960788-85960802 chr6:85960789-85960800 chr6:85960790-85960799 |
41 | STAT3 | chr6:85960529-85961002 | MCF10A-Er-Src | breast: | n/a | chr6:85960791-85960814 chr6:85960791-85960800 chr6:85960788-85960802 chr6:85960789-85960800 chr6:85960790-85960799 |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000216902 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs147232932 | chr6:85945210-85945211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs192077414 | chr6:85945234-85945235 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs528936957 | chr6:85945270-85945271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs183218217 | chr6:85945284-85945285 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs187936282 | chr6:85945286-85945287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs189717451 | chr6:85945360-85945361 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs528338785 | chr6:85945376-85945377 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs551664886 | chr6:85945400-85945401 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs566666444 | chr6:85945414-85945415 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs527445054 | chr6:85945455-85945456 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs549499434 | chr6:85945475-85945476 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs182368770 | chr6:85945479-85945480 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs537879276 | chr6:85945504-85945505 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs556162565 | chr6:85945526-85945527 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs148716301 | chr6:85945542-85945543 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs115969740 | chr6:85945567-85945568 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs1321728 | chr6:85945575-85945576 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs76948967 | chr6:85945597-85945598 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs542842995 | chr6:85945627-85945628 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs555472917 | chr6:85945640-85945641 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs16875897 | chr6:85945680-85945681 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs16875898 | chr6:85945716-85945717 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs1358834 | chr6:85945834-85945835 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs532914194 | chr6:85945840-85945841 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs545288850 | chr6:85945900-85945901 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs560181745 | chr6:85945952-85945953 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs73750417 | chr6:85946042-85946043 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs80042828 | chr6:85946054-85946055 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs374870665 | chr6:85946126-85946127 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs142731750 | chr6:85946132-85946133 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs187974133 | chr6:85946144-85946145 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs151005234 | chr6:85946162-85946163 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs571313141 | chr6:85946176-85946177 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs376506953 | chr6:85946233-85946234 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs557189355 | chr6:85946234-85946235 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs538644248 | chr6:85946315-85946316 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs372044638 | chr6:85946317-85946318 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs192656545 | chr6:85946354-85946355 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs567637594 | chr6:85946359-85946360 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs16875899 | chr6:85946402-85946403 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs536878513 | chr6:85946418-85946419 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs144743690 | chr6:85946451-85946452 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs527407674 | chr6:85946458-85946459 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs35184861 | chr6:85946470-85946471 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs700499 | chr6:85946501-85946502 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs537947407 | chr6:85946513-85946514 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs556245144 | chr6:85946516-85946517 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs577756884 | chr6:85946526-85946527 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs544666306 | chr6:85946529-85946530 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs570636492 | chr6:85946544-85946545 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
Breast cancer | 17133270 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Prostate cancer | 16461572 | CNVD |
Mental retardation | 21045960 | CNVD |
Obesity | 21045960 | CNVD |
learning difficulties | 21045960 | CNVD |
Prostate cancer | 17245344 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abnormal development | 18461090 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:85945200-85947600 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
2 | chr6:85946000-85946200 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
3 | chr6:85946200-85947200 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
4 | chr6:85947200-85947600 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
5 | chr6:85947400-85948000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
6 | chr6:85947600-85949600 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
7 | chr6:85949600-85952000 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
8 | chr6:85950400-85951000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
9 | chr6:85950400-85951000 | Enhancers | Osteobl | bone |
10 | chr6:85950400-85951400 | Enhancers | HUVEC | blood vessel |
11 | chr6:85950400-85952000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
12 | chr6:85954600-85955000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
13 | chr6:85958400-85962600 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr6:85960200-85961600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
15 | chr6:85960400-85961400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
16 | chr6:85960400-85962800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
17 | chr6:85960600-85961000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
18 | chr6:85960600-85961000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
19 | chr6:85960600-85961200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
20 | chr6:85960600-85961200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
21 | chr6:85960600-85961200 | Enhancers | Osteobl | bone |
22 | chr6:85960600-85961400 | Enhancers | Hela-S3 | cervix |
23 | chr6:85960800-85961400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
24 | chr6:85960800-85961400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
25 | chr6:85961000-85961400 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |